AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 279: F130-F143, 2000;
0363-6127/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (93)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hruska, K. A.
Right arrow Articles by Morrissey, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hruska, K. A.
Right arrow Articles by Morrissey, J.
Vol. 279, Issue 1, F130-F143, July 2000

Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction

Keith A. Hruska1,2, Guangjie Guo1,2, Magdalena Wozniak1, Daniel Martin1, Steven Miller1, Helen Liapis3, Kenneth Loveday4, Saulo Klahr1, T. Kuber Sampath4, and Jeremiah Morrissey1,2

1 Renal Division, Departments of Medicine, 2 Cell Biology, and 3 Pathology, Barnes-Jewish Hospital at Washington University, St. Louis, Missouri 63110; and 4 Creative Biomolecules, Hopkinton, Massachusetts 01748

Unilateral ureteral obstruction (UUO) is a model of renal injury characterized by progressive tubulointerstitial fibrosis and renal damage, while relatively sparing the glomerulus and not producing hypertension or abnormalities in lipid metabolism. Tubulointerstitial fibrosis is a major component of several kidney diseases associated with the progression to end-stage renal failure. Here we report that when a critical renal developmental morphogen, osteogenic protein-1 (OP-1; 100 or 300 µg/kg body wt), is administered at the time of UUO and every other day thereafter, interstitial inflammation and fibrogenesis are prevented, leading to preservation of renal function during the first 5 days after obstruction. Compared with angiotensin-converting enzyme inhibition with enalapril treatment, OP-1 was more effective in preventing tubulointerstitial fibrosis and in preserving renal function. The mechanism of OP-1- induced renal protection was associated with prevention of tubular atrophy, an effect not shared with enalapril, and was related to preservation of tubular epithelial integrity. OP-1 blocked the stimulation of epithelial cell apoptosis produced by UUO, which promoted maintenance of tubular epithelial integrity. OP-1 preserved renal blood flow (RBF) during UUO, but enalapril also stimulated RBF. Thus OP-1 treatment inhibited tubular epithelial disruption stimulated by the renal injury of UUO, preventing tubular atrophy and diminishing the activation of tubulointerstitial inflammation and fibrosis and preserving renal function.

kidney morphogens; tubulointerstitial fibrosis; renal failure; tubular atrophy


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
I. Kazama, Z. Mahoney, J. H. Miner, D. Graf, A. N. Economides, and J. A. Kreidberg
Podocyte-Derived BMP7 Is Critical for Nephron Development
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2181 - 2191.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Murphy, N. G. Docherty, B. Griffin, J. Howlin, E. McArdle, R. McMahon, H. Schmid, M. Kretzler, A. Droguett, S. Mezzano, et al.
IHG-1 Amplifies TGF-{beta}1 Signaling and Is Increased in Renal Fibrosis
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1672 - 1680.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Boor, K. Sebekova, T. Ostendorf, and J. Floege
Treatment targets in renal fibrosis
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
J. T. Buijs, N. V. Henriquez, P. G.M. van Overveld, G. van der Horst, I. Que, R. Schwaninger, C. Rentsch, P. ten Dijke, A.-M. Cleton-Jansen, K. Driouch, et al.
Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
Cancer Res., September 15, 2007; 67(18): 8742 - 8751.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Sugimoto, G. Grahovac, M. Zeisberg, and R. Kalluri
Renal Fibrosis and Glomerulosclerosis in a New Mouse Model of Diabetic Nephropathy and Its Regression by Bone Morphogenic Protein-7 and Advanced Glycation End Product Inhibitors
Diabetes, July 1, 2007; 56(7): 1825 - 1833.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Wilkinson, T. Gilbert, G. Kinna, L.-A. Ruta, D. Pennisi, M. Kett, and M. H. Little
Crim1KST264/KST264 Mice Implicate Crim1 in the Regulation of Vascular Endothelial Growth Factor-A Activity during Glomerular Vascular Development
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1697 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. Otani, F. Otsuka, K. Inagaki, M. Takeda, T. Miyoshi, J. Suzuki, T. Mukai, T. Ogura, and H. Makino
Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1513 - F1525.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
H. Sugimoto, C. Yang, V. S. LeBleu, M. A. Soubasakos, M. Giraldo, M. Zeisberg, and R. Kalluri
BMP-7 functions as a novel hormone to facilitate liver regeneration
FASEB J, January 1, 2007; 21(1): 256 - 264.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
F. Strutz and M. Zeisberg
Renal Fibroblasts and Myofibroblasts in Chronic Kidney Disease
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2992 - 2998.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. A. Eddy
Ramping up endogenous defences against chronic kidney disease
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1174 - 1177.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Zeisberg
Bone morphogenic protein-7 and the kidney: current concepts and open questions
Nephrol. Dial. Transplant., March 1, 2006; 21(3): 568 - 573.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
N. G. Docherty, O. E. O'Sullivan, D. A. Healy, J. M. Fitzpatrick, and R. W. G. Watson
Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction
Am J Physiol Renal Physiol, January 1, 2006; 290(1): F4 - F13.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
C. Chatziantoniou and J.-C. Dussaule
Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F227 - F234.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P Merkel, G. Lo, J. Holbrook, A. Tibbs, N. Allen, J. Davis, G. Hoffman, W. McCune, E. St Clair, U Specks, et al.
Thromboembolism--Another Threat to the Polymorbid Patient with Vasculitis?: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 142: 620-626, 2005
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1871 - 1877.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Yamashita, A. Maeshima, and Y. Nojima
Involvement of Renal Progenitor Tubular Cells in Epithelial-to-Mesenchymal Transition in Fibrotic Rat Kidneys
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2044 - 2051.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Zeisberg, A. A. Shah, and R. Kalluri
Bone Morphogenic Protein-7 Induces Mesenchymal to Epithelial Transition in Adult Renal Fibroblasts and Facilitates Regeneration of Injured Kidney
J. Biol. Chem., March 4, 2005; 280(9): 8094 - 8100.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. Hirschberg
Wound Healing in the Kidney: Complex Interactions in Renal Interstitial Fibrogenesis
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 9 - 11.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
X. L. Zhang, W. Selbi, C. de la Motte, V. Hascall, and A. O. Phillips
Bone Morphogenic Protein-7 Inhibits Monocyte-Stimulated TGF-{beta}1 Generation in Renal Proximal Tubular Epithelial Cells
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 79 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
P. H. Dube, M. M. Almanzar, K. S. Frazier, W. K. Jones, M. F. Charette, and A. Paredes
Osteogenic Protein-1: Gene Expression and Treatment in the Rat Remnant Kidney Model
Toxicol Pathol, June 1, 2004; 32(4): 384 - 392.
[Abstract] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Zeisberg, G. A. Muller, and R. Kalluri
Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7)
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 759 - 761.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Yamashita, A. Maeshima, I. Kojima, and Y. Nojima
Activin A Is a Potent Activator of Renal Interstitial Fibroblasts
J. Am. Soc. Nephrol., January 1, 2004; 15(1): 91 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. Zeisberg, C. Bottiglio, N. Kumar, Y. Maeshima, F. Strutz, G. A. Muller, and R. Kalluri
Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models
Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1060 - F1067.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
H. T. Yu
Progression of Chronic Renal Failure
Arch Intern Med, June 23, 2003; 163(12): 1417 - 1429.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Wang and R. Hirschberg
BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells
Am J Physiol Renal Physiol, May 1, 2003; 284(5): F1006 - F1013.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Klahr and J. Morrissey
Obstructive nephropathy and renal fibrosis
Am J Physiol Renal Physiol, November 1, 2002; 283(5): F861 - F875.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Schiffer, L. E. Schiffer, A. Gupta, A. S. Shaw, I. S.D. Roberts, P. Mundel, and E. P. Bottinger
Inhibitory Smads and TGF-{beta} Signaling in Glomerular Cells
J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2657 - 2666.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
A. Rosendahl, E. Pardali, M. Speletas, P. ten Dijke, C.-H. Heldin, and P. Sideras
Activation of Bone Morphogenetic Protein/Smad Signaling in Bronchial Epithelial Cells during Airway Inflammation
Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 160 - 169.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. Morrissey, G. Guo, K. Moridaira, M. Fitzgerald, R. McCracken, T. Tolley, and S. Klahr
Transforming Growth Factor-{beta} Induces Renal Epithelial Jagged-1 Expression in Fibrotic Disease
J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1499 - 1508.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S.-N. WANG, J. LAPAGE, and R. HIRSCHBERG
Loss of Tubular Bone Morphogenetic Protein--7 in Diabetic Nephropathy
J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2392 - 2399.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online